Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., . . . Caers, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease. Haematologica.
Styl cytowania ChicagoMuller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.
Styl cytowania MLAMuller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..